Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism mGluR1 modulators(Metabotropic glutamate receptor 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H21F3N4O3S |
InChIKeyCDKQYHRJSPMXKH-UHFFFAOYSA-N |
CAS Registry2001593-26-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 15 Jun 2018 |